Penserra Capital Management LLC Mannkind Corp Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$4.05 - $5.37 $23,125 - $30,662	-5,710 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.89 - $5.48 $155 - $219	40 Added 0.71%	5,710 $24,000
Q2 2021 Aug 12, 2021	BUY	$3.61 - $5.45 $180 - $272	50 Added 0.89%	5,670 $30,000
Q1 2021 May 13, 2021	BUY	$3.14 - $6.14 $894 - $1,749	285 Added 5.34%	5,620 $22,000
Q4 2020 Feb 12, 2021	BUY	$1.79 - $4.04 $6,051 - $13,659	3,381 Added 173.03%	5,335 $16,000
Q3 2020 Nov 13, 2020	BUY	$1.56 - $2.08 $3,048 - $4,064	1,954 New	1,954 $3,000

242

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.55B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.